Associated Papers
Methotrexate pharmacogenetics in Uruguayan adults with hematological malignant diseases.
Giletti A et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences, 2017
Association of MTHFR C677T and A1298C gene polymorphisms with methotrexate efficiency and toxicity in Algerian rheumatoid arthritis patients.
Berkani LM et al.
Heliyon, 2017
The Promise of Pharmacogenomics in Reducing Toxicity During Acute Lymphoblastic Leukemia Maintenance Treatment.
Rudin S et al.
Genomics, Proteomics & Bioinformatics, 2017
The effect of gene polymorphisms on patient responses to rheumatoid arthritis therapy.
Tarnowski M et al.
Expert Opinion on Drug Metabolism & Toxicology, 2016
Effect of genetic polymorphisms involved in folate metabolism on the concentration of serum folate and plasma total homocysteine (p-tHcy) in healthy subjects after short-term folic acid supplementation: a randomized, double blind, crossover study.
Cabo R et al.
Genes & Nutrition, 2015
Pharmacogenetic considerations for acute lymphoblastic leukemia therapies.
Dulucq S et al.
Expert Opinion on Drug Metabolism & Toxicology, 2014
Host genetic variants of ABCB1 and IL15 influence treatment outcome in paediatric acute lymphoblastic leukaemia.
Lu Y et al.
British Journal of Cancer, 2014
The genetic architecture of methotrexate toxicity is similar in Drosophila melanogaster and humans.
Kislukhin G et al.
G3 (bethesda, Md.), 2013
Polymorphisms in genes involved in folate metabolism and orofacial clefts.
Bhaskar LV et al.
Archives of Oral Biology, 2011
Genes and abdominal aortic aneurysm.
Hinterseher I et al.
Annals of Vascular Surgery, 2011
Genetic polymorphisms of genes involved in DNA repair and metabolism influence micronucleus frequencies in human peripheral blood lymphocytes.
Dhillon VS et al.
Mutagenesis, 2011
Investigation of inter-individual variability of the one-carbon folate pathway: a bioinformatic and genetic review.
Carr DF et al.
The Pharmacogenomics Journal, 2009
Reduced folate carrier 80A-->G polymorphism, plasma folate, and risk of placental abruption.
Ananth CV et al.
Human Genetics, 2008
Pharmacogenetics of acute lymphoblastic leukemia treatment response.
Cunningham L et al.
Expert Opinion on Pharmacotherapy, 2007
G80A reduced folate carrier SNP influences the absorption and cellular translocation of dietary folate and its association with blood pressure in an elderly population.
Dufficy L et al.
Life Sciences, 2006
Genetic variation of folate-mediated one-carbon transfer pathway predicts susceptibility to choline deficiency in humans.
Kohlmeier M et al.
Proceedings of the National Academy of Sciences of the United States of America, 2005